Report Scope:
This report incorporates an in-depth analysis of the renal biomarker market, including market estimations and trends through 2021. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The patent analysis focuses on technological trends in recent years in regions such as the U.S., Europe, and Japan. The report presents a market analysis and estimates the CAGR for renal biomarkers.
The scope of the report extends only to renal biomarker consumables and not devices used to study renal biomarkers. All types of renal biomarkers have been considered in research, clinical trials and for diagnostic purposes.
This report segments the global market by these geographic regions: North America, Europe, Asia-Pacific, and the Rest of the World (RoW) region. For market estimates, data is provided for 2021 as the base year, 2022 and forecast through year-end 2027.
Report Includes:
- 41 data tables and 24 additional tables
- A detailed overview and up-to-date analysis of the global markets for renal biomarkers
- Analyses of the global market trends, with market revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Estimation of the actual market size and revenue forecast for renal biomarkers market, and corresponding market share analysis by assay type, application, end user, and region
- Updated information on market drivers and opportunities for renal biomarkers, key shifts, regulations and industry specific challenges, and other demographic factors that will shape the market demand over the coming years (2022-2027)
- Identification of the companies best positioned to meet the demand owing to their proprietary technologies, product launches, mergers and acquisitions, and other market strategic advantages
- Review of recent industry structure for biomarkers, R&D activities, and analysis of the competitive landscape based on recent developments and segmental revenues
- Patent activity and review of patent grants for biomarkers and related technologies
- Descriptive company profiles of the market leading players, including BioMerieux, Gentian Diagnostic, Proteomics International, Thermo Fisher Scientific, SphingoTec, and BioPorto
Summary:
The global market for renal biomarkers reached $REDACTED billion in 2021. The market is expected to grow at acompound annual growth rate (CAGR) of REDACTED% to reach $REDACTED billion during the forecast period.
The renal biomarker market is growing at a steady pace due the increasing prevalence and incidence of the two major kidney diseases: acute kidney injury (AKI) and chronic kidney disease (CKD). These diseases increase hospitalization time, leading to higher costs and morbidity. Early identification of such diseases leads to better treatment, which is possible through biomarkers.
COVID-19 has had a huge impact in increasing the incidence of kidney diseases. Long-term COVID patients have a higher incidence of AKI or CKD. The prevalence of lifestyle diseases such as diabetes and hypertension is also rising. These are closely associated with kidney disorders and malfunction. These diseases are currently the 16th leading cause of death but are expected to be fifth leading by 2030.
The traditional biomarkers used for detecting AKI and CKD have many disadvantages compared to new and novel biomarkers. New biomarkers are being studied and discovered, as there is a gap for an ideal renal biomarker. There is no single renal tumor biomarker that can be pursued by the industry.
Renal Biomarkers: Technologies and Global Markets
Table of Contents
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing this Study
1.3 What's New in this Report
1.4 Scope of Report
1.5 Information Sources
1.6 Methodology
1.7 Geographic Breakdown
1.8 Analyst's Credentials
1.9 BCC Custom Research
1.10 Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
3.1 Introduction
3.1.1 Kidneys
3.1.2 Renal Biomarkers
3.1.3 Definition
3.2 Market Dynamics
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunities
3.3 Regulatory Process for Biomarkers
3.3.1 European Medicines Agency
3.3.2 Biomarkers Qualified by the FDA
Chapter 4 Impact of COVID-19 Pandemic
4.1 Impact of COVID-19 on Renal Biomarker Market
4.1.1 Increased Incidence of AKI
4.1.2 Other Diseases
4.2 Chronic Dialysis Patients
4.2.1 Kidney Transplant Recipients
Chapter 5 Global Renal Biomarker Market by Type
5.1 Overview
5.2 Filtered Renal Biomarkers (Impaired Tubular Reabsorption)
5.2.1 Albumin
5.2.2 Cystatin C
5.2.3 Beta-2 Microglobulin
5.3 Upregulated Biomarkers
5.3.1 KIM-1 Kidney Injury Molecule
5.3.2 Neutrophil Gelatinase Associated Lipocalin
5.3.3 Clusterin
5.3.4 Interleukin-18
5.3.5 Netrin-1
5.4 Preformed
5.4.1 Alkaline Phosphatase
5.4.2 Gamma-Glutamyl Transpeptidase
5.4.3 Glutathione S-Transferase
5.4.4 N-acetyl-ß-D Glucosaminidase
5.4.5 Liver-Type Fatty Acid-Binding Protein
5.4.6 Tissue Inhibitor of Metalloprotease-2 and Insulin-Like Growth Factor-binding Protein 7
5.5 Other Biomarkers
5.5.1 Blood Urea Nitrogen
5.5.2 Serum Creatinine
5.5.3 Downregulated
Chapter 6 Global Market for Renal Biomarkers by Region
6.1 North America
6.1.1 United States
6.1.2 Canada
6.2 Europe
6.2.1 Germany
6.2.2 Italy
6.2.3 France
6.2.4 Spain
6.2.5 United Kingdom
6.2.6 Rest of Europe
6.3 Asia-Pacific
6.3.1 Australia
6.3.2 Japan
6.3.3 China
6.3.4 Rest of Asia
6.4 Rest of the World
Chapter 7 Renal Biomarker Market by End User
7.1 Hospitals
7.2 Research Centers
7.3 Other End Users
Chapter 8 Renal Biomarker Market by Technique
8.1 Overview
8.2 Enzyme Linked Immunosorbent Assay
8.3 Particle-Enhanced Turbidimetric Immunoassays
8.4 Colorimetric Assays
8.5 Chemiluminescent Enzyme Immunoassays
8.6 Other Detection Methods
Chapter 9 Competitive Landscape
Chapter 10 Company Profiles
ABBOTT LABORATORIES
BECKMAN COULTER INC.
BIOMERIEUX
BIOPORTO A/S
BIO-RAD
ENZO BIOCHEM INC.
GENTIAN DIAGNOSTIC AB
HYTEST LTD.
NEPHROSANT
Nexelis
PROTEOMICS INTERNATIONAL LABORATORIES LTD.
RANDOX LABORATORIES LTD.
ROCHE (F. HOFFMANN-LA ROCHE AG)
SPHINGOTEC
THERMO FISHER SCIENTIFIC
Chapter 11 Patent Review
Chapter 12 Clinical Trial Analysis
List of Tables
Summary Table : Global Market for Renal Biomarkers, by Segment, Through 2027
Table 1 : Applications for Biomarkers, with Examples
Table 2 : Changes in Aging Kidneys
Table 3 : Qualified Biomarkers of EMA SAWP/CHMP, as of March 30, 2020
Table 4 : Stages in the FDA Biomarker Qualification Program
Table 5 : Qualified Biomarkers for FDA CDER BQP, as of Feb. 19, 2020
Table 6 : Cases of COVID-19 and Related Deaths, by Country, as of October 2022
Table 7 : Effects of COVID-19 on Kidney Disease Patients
Table 8 : Properties of KIM-1
Table 9 : Global Market for Renal Biomarkers, by Region, Through 2027
Table 10 : AKI in Developed and Developing Countries
Table 11 : North American Market for Renal Biomarkers, by Country, Through 2027
Table 12 : North American Market for Renal Biomarkers, by Type, Through 2027
Table 13 : U.S. Market for Renal Biomarkers, by Type, Through 2027
Table 14 : Canadian Market for Renal Biomarkers, by Type, Through 2027
Table 15 : European Kidney Health Alliance Recommendations
Table 16 : European Market for Renal Biomarkers, by Region, Through 2027
Table 17 : European Market for Renal Biomarkers, by Type, Through 2027
Table 18 : German Market for Renal Biomarkers, by Type, Through 2027
Table 19 : Italian Market for Renal Biomarkers, by Type, Through 2027
Table 20 : French Market for Renal Biomarkers, by Type, Through 2027
Table 21 : Spanish Market for Renal Biomarkers, by Type, Through 2027
Table 22 : U.K. Market for Renal Biomarkers, by Type, Through 2027
Table 23 : Rest of Europe Market for Renal Biomarkers, by Type, Through 2027
Table 24 : Asia-Pacific Market for Renal Biomarkers, by Country, Through 2027
Table 25 : Asia-Pacific Market for Renal Biomarkers, by Type, Through 2027
Table 26 : Australian Market for Renal Biomarkers, by Type, Through 2027
Table 27 : Japanese Market for Renal Biomarkers, by Type, Through 2027
Table 28 : Chinese Market for Renal Biomarkers, by Type, Through 2027
Table 29 : Rest of Asia Market for Renal Biomarkers, by Type, Through 2027
Table 30 : RoW Market for Renal Biomarkers, by Type, Through 2027
Table 31 : Global Market for Renal Biomarkers, by End User, Through 2027
Table 32 : Global Market for Renal Biomarkers, by Technique, Through 2027
Table 33 : Methods for Detection of Renal Biomarkers
Table 34 : Company Developments, 2019-2022
Table 35 : Abbott Laboratories: Renal Biomarker Portfolio
Table 36 : Abbott Laboratories: Revenue and R&D Expenses, 2019 to 2021
Table 37 : Abbott Laboratories: Revenue, by Segment
Table 38 : BioMerieux: Revenue and R&D Expenditure, 2019-2021
Table 39 : BioMerieux: Revenue of Immunoassay Segment, 2019-2021
Table 40 : BioMerieux: Recent Developments, 2019-2022
Table 41 : Bioporto: Revenue and R&D Expense, 2019-2021
Table 42 : Bioporto: NGAL Revenue, 2019-2021
Table 43 : Bioporto: Recent Developments, 2019-2022
Table 44 : Bio-Rad: Kidney Toxicity Assay Portfolio
Table 45 : Bio-Rad: Revenue and R&D Expense, 2019-2021
Table 46 : Enzo Biochem: Revenue and R&D Expenses, 2019-2021
Table 47 : Enzo Biochem: Revenue, by Segment, 2019-2021
Table 48 : Enzo Biochem: Revenue, by Region, 2019 to 2021
Table 49 : Gentian Diagnostic: Revenue, by Region, 2019-2021
Table 50 : Gentian Diagnostic: Recent Developments, 2019-2022
Table 51 : Nexelis: Recent Developments, 2019-2022
Table 52 : Nexelis: Renal Biomarker Portfolio
Table 53 : Proteomics International: Revenue, 2019-2022
Table 54 : Proteomics: Recent Developments, 2019-2022
Table 55 : Roche: Revenue and R&D Expenses, 2019-2021
Table 56 : Roche: Revenue, by Segment, 2019-2021
Table 57 : Roche: Revenue, by Diagnostic Segment, 2019-2021
Table 58 : Roche: Revenue, by Region, 2019 to 2022
Table 59 : Sphingotec: Recent Developments, 2019-2022
Table 60 : Thermo Fisher Scientific: Revenue and R&D Expenses, 2019-2021
Table 61 : Thermo Fisher Scientific: Revenue, by Segment, 2019-2021
Table 62 : Thermo Fisher Scientific: Recent Developments, 2019-2022
Table 63 : Precision Medicine Patent Criteria in U.S. and Europe
Table 64 : List of Renal Biomarker Patents
List of Figures
Summary Figure : Global Market for Renal Biomarkers, by Type, 2019-2027
Figure 1 : Applications for Biomarkers
Figure 2 : Timeline for Renal Biomarkers
Figure 3 : Initial Timeline of EMA Biomarker Qualification
Figure 4 : Flowchart of EMA Biomarker Qualification Process
Figure 5 : Steps in EMA Biomarker Qualification
Figure 6 : Steps in Biomarker Quantification
Figure 7 : Pathways for Excretion of IGFBP7 and TIMP-2
Figure 8 : Percentage of CKD Patients, by Age, in U.S.
Figure 9 : Number of Patients Receiving Kidney Dialysis in Canada
Figure 10 : EU Patients Undergoing Kidney Dialysis and Transplants
Figure 11 : Shares of Leading Companies in the Renal Biomarker Market
Figure 12 : Clinical Trials of Renal Biomarkers, by Therapeutic Area, 2019 to October 2022
Figure 13 : Clinical Trials of Renal Biomarkers, by Sponsor
Figure 14 : Clinical Trials of Renal Biomarkers, by Location
Global Biomarkers Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 94
According to our LPI (LP Information) latest study, the global Biomarkers market size was valued at US$ 61570 million in 2023. With growing demand in downstream market, the Biomarkers is forecast to a readjusted size of US$ 165240 million by 2030 with a CAGR of 15.1% during review period.
The research report highlights the growth potential of the global Biomarkers market. Biomarkers are expected to show stable growth in the future market. However, product differentiation, reducing costs,......
Global Biomarker (Medicine) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 114
Market Overview of Global Biomarker (Medicine) market:
According to our latest research, the global Biomarker (Medicine) market looks promising in the next 5 years. As of 2022, the global Biomarker (Medicine) market was estimated at USD 54332.95 million, and it's anticipated to reach USD 82760.29 million in 2028, with a CAGR of 7.27% during the forecast years.
Biomarkers (short for biological markers) are biological measures of a biological state. By definition, a biomarker i......
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 131
According to our LPI (LP Information) latest study, the global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market size was valued at US$ 20920 million in 2023. With growing demand in downstream market, the Commercializing Biomarkers in Therapeutic and Diagnostic Applications is forecast to a readjusted size of US$ 29400 million by 2030 with a CAGR of 5.0% during review period.
The research report highlights the growth potential of the global Commercializing Biom......
Global Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 05-Dec-2023 Price: US 3380 Onwards Pages: 100
Market Overview of Global Biomarkers market:
According to our latest research, the global Biomarkers market looks promising in the next 5 years. As of 2022, the global Biomarkers market was estimated at USD 76755.97 million, and it's anticipated to reach USD 184776.75 million in 2028, with a CAGR of 15.77% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Biomarkers market, with a......
Global Biomarker Technology Market Research Report 2023
Published: 01-Dec-2023 Price: US 2900 Onwards Pages: 86
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biomarker Technology market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Abbott Laboratories
- Quanterix
- Bio-Rad Laboratories
- Epigenomics
- Agilent Technologies
- Johnson & Johnson
- Qiagen
- Roche Ho......
Global Renal Biomarkers Market Research Report 2023
Published: 01-Dec-2023 Price: US 2900 Onwards Pages: 99
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Renal Biomarkers market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Abbott Diagnostics
- F. Hoffmann-La Roche
- Beckman Coulter
- Siemens Healthcare Diagnostics
- Thermo Fisher Scientific
- Astute Medical
- Bio......
Global Central Nervous System (CNS) Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 30-Nov-2023 Price: US 3380 Onwards Pages: 114
Market Overview of Global Central Nervous System (CNS) Biomarkers market:
According to our latest research, the global Central Nervous System (CNS) Biomarkers market looks promising in the next 5 years. As of 2022, the global Central Nervous System (CNS) Biomarkers market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
An overview of the global market for central nervous system (CNS) biomarke......
Global Cancer Biomarker Market Research Report 2023
Published: 13-Nov-2023 Price: US 2900 Onwards Pages: 109
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cancer Biomarker market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Roche Diagnostics
- Qiagen
- Illumina
- GE Healthcare
- Agilent Technologies
- Biomér......
Biomarker Collaboration and Licensing Deals 2016-2023
Published: 01-Nov-2023 Price: US 3995 Onwards Pages: 300
Biomarker Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the biomarker deals entered into by the worlds leading biopharma companies.
Fully revised and updated, the report provides details of biomarker deals from 2016 to 2023.
The report provides a detailed understanding and analysis of how and why companies enter biomarker deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercializ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
